Governor Martin O’Malley announced today that the State, through the BioMaryland Center, has awarded nearly $1 million to five innovative life sciences companies through its Biotechnology Development Awards program. The companies, which received up to $200,000 each, will use the funding to advance the early detection of Alzheimer’s disease, create a less-invasive treatment for tachycardia patients, enhance animal analgesics, control traumatic bleeds and develop high-quality gluten and allergen-free kosher food products.
“These companies are developing products that are changing the way we feed, fuel and heal our planet and have the potential to impact millions of patients around the world,” said Governor O’Malley. “These awards are critical to ensuring that the life-saving research being done here in Maryland has the opportunity to move to the commercial marketplace.”
To read the full, original article click on this link: BioMaryland Center Awards Million to Accelerate Commercialization at Six Life Sciences Companies